CD4 and breast cancer: Moreover, in vitro data from one study indicated that CCL2 could activate neutrophils and mediate the killing of breast cancer cells, whereas in mice breast cancer models, intranasal administration of CCL2 protein was able to increase the recruitment of CD4+ T cells in the lung, favoring tumor dissemination, and metastasis to the lung.124